As the capabilities of generative AI models have grown, you've probably seen how they can transform simple text prompts into hyperrealistic images and even extended video clips. More recently, ...

The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (EVGN), a leading ...

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications In both pharma and ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...

Chemists have found a new way to determine 3D genome structures, using generative AI, that can predict thousands of genome structures in minutes, making it much speedier than existing methods for ...

Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

To obtain a systematic view of Pharma.AI, the generative AI-driven solution for drug discovery and more cutting-edge research, please refer to the following answers provided by the Insilico AI team.

REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and ...